MOORESTOWN, N.J., March 14, 2018 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital software solutions and novel, proprietary medication decision support tools, today announced that Chief Financial Officer, Brian Adams, will participate in Oppenheimer 28th Annual Healthcare Conference in New York City.
The TRHC Management Team’s presentation is scheduled on Wednesday, March 21, 2018 at 8:00 a.m. EDT.
About Tabula Rasa HealthCare
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable health care organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, www.TRHC.com.
Contact:
Investors
Bob East or Asher Dewhurst
Westwicke Partners
443-213-0500
[email protected]
Media
Dianne Semingson
[email protected]
T: 215-870-0829


DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Jetstar to Charge for Overhead Cabin Bags From February
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 



